Analyst picks & changes

Biogen Inc. (BGEN), Cambridge, Mass. Business: Biopharmaceuticals Leerink Swann analyst Jennifer Chao began coverage with a "buy" and a $76 price target. She said the Street has undervalued BGEN share...